Article & Resources
Mounting Evidence for Single-Freehand Local Anaesthetic Transperineal Prostate Biopsy
BXTAccelyon verhoogt opnieuw zijn inzet voor Europese expansie met een nieuwe locatie in Nederland
BXTAccelyon increases commitment to European expansion with new locations in the Netherlands
BAUN Conference highlight: “Nurses are key to eradicating transrectal prostate biopsy”
A new, independent report from the York Health Economics Consortium (YHEC) on prostate cancer biopsies, has validated the improved health outcomes and economic benefits of the PrecisionPointTM transperineal prostate biopsy methodology under local anaesthetic (LA TP).
BXTA welcomes European Commercial Leader & Clinical Applications Specialist team members amidst continued international growth.
Nurse-led service transformation: a pathway to professional advancement – and better patient care
A new research paper recently published gives further weight to the eradication of the transrectal (TR) prostate biopsy from the prostate cancer pathway.
New study adds evidence to the important role of MRI & systematic biopsy in prostate cancer diagnosis
Patients treated with Low Dose Rate Brachytherapy boost therapy in combination with External Beam Radiotherapy achieve more effective PSA control
THE SOUTH WEST CANCER ALLIANCE MOVES TOWARDS ERADICATION OF ‘TRUS’ PROSTATE CANCER BIOPSY
BXTACCELYON BECOMES GLOBAL DISTRIBUTION PARTNER FOR NEW ONLINE PROSTATE MRI SELF-LEARNING TOOL, MRI PRO, TO ENHANCE PROSTATE CANCER DIAGNOSIS
State of the Art Stokes Centre for Urology to host Two-day Uro-Oncology Masterclass covering latest Innovations in Prostate Cancer Pathway
Prostate cancer in Scotland: an evolutionary journey By Karen Walker, Clinical Nurse Specialist,Edinburgh Cancer Centre
BXTAccelyon attend the 9th Annual Urology in General Practice (UroGP) Symposium 2018
LDR Brachytherapy: A minimally invasive curative treatment with excellent oncological and functional outcomes
Better Quality of life scores after brachytherapy in comparison to radical prostatectomy
Maidstone Hospital is this year’s host for the UK & Ireland Prostate Brachytherapy Conference
Cost effectiveness study highlights benefits of new ‘4D’ technique for low dose rate brachytherapy
Dismissal of ASCENDE-RT LDR boost findings restricts life-enhancing treatment opportunities
Low Dose Rate Brachytherapy Boost: Latest Scientific Evidence on Outcome Survival Rates Indicates LD
BXTAccelyon becomes sole distribution partner for new transperineal prostate biopsy device
Active Surveillance or Another Prostate Cancer Treatment? Choices Linked to Quality of Life
Inside Health – BBC Radio 4 discusses uncertainty in the diagnosis and treatment of prostate cancer
Article claiming lower mortality for surgery verses radiotherapy could be misleading
ASCENDE RT study: intermediate and high risk prostate cancer patients have double the survival chance with brachytherapy seeds
Implants boost odds of halting prostate cancer: Men treated with radioactive ‘seeds’ twice as likely to find disease has stabilised after five years
Sorry, there are currently no posts with that category.